Connect with us

Health

Ozempic patients may face dangerous risks during surgery, doctors warn

Published

on

Ozempic patients may face dangerous risks during surgery, doctors warn

Join Fox News for access to this content

You have reached your maximum number of articles. Log in or create an account FREE of charge to continue reading.

By entering your email and pushing continue, you are agreeing to Fox News’ Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive.

Please enter a valid email address.

Having trouble? Click here.

Patients who are taking GLP-1 medications such as Ozempic, Wegovy, Mounjaro and others could face complications during surgery, recent research has shown.

In one study led by UTHealth Houston, more than half of patients taking GLP-1s had “significant gastric contents” before going into surgery, even if they had followed pre-op fasting protocols, according to a press release on the university’s website.

Advertisement

This could lead to a potentially life-threatening condition called pulmonary aspiration, when food or liquid is inhaled into the lungs.

OZEMPIC AND WEGOVY COULD DOUBLE AS KIDNEY DISEASE TREATMENT, STUDY SUGGESTS

GLP-1 (glucagon-like peptide) receptor agonists are commonly prescribed to patients with type 2 diabetes (to stabilize blood glucose levels) or obesity (to assist with weight loss).

“These medications slow down digestion, which means food stays in the stomach longer,” said Dr. Alfred Bonati, the founder of the Bonati Spine Institute in Florida.

Patients who are taking GLP-1 medications such as Ozempic, Wegovy, Mounjaro and others could face complications during surgery, recent research has shown. (iStock; Getty Images)

Advertisement

Pulmonary aspiration can cause severe lung damage, infections or even death, Bonati warned.

“General anesthesia can also cause nausea, and the slowed digestion from weight-loss meds can exacerbate this, leading to a higher risk of vomiting during surgery,” he said.

“These medications slow down digestion, which means food stays in the stomach longer.”

Dr. Brett Osborn, a board-certified neurosurgeon and section chief at St. Mary’s Medical Center in Florida, always advises his patients who are taking GLP-1 agonists to stop the medication at least one week before a surgical procedure, he said. 

In addition to aspiration, Osborn warned of the increased risk of postoperative ileus, a dysfunction of the intestines after surgery.

Advertisement

GLP-1 (glucagon-like peptide) receptor agonists are commonly prescribed to patients with type 2 diabetes, to stabilize blood glucose levels — or patients with obesity, to assist with weight loss. (iStock)

“This could predispose patients to significant problems, including bowel ischemia (a rare circulatory condition that occurs when blood flow to the intestines is reduced),” he told Fox News Digital.

Healing is a secondary concern among patients taking GLP-1s, according to Osborn. 

OZEMPIC BABIES: WOMEN CLAIM WEIGHT-LOSS DRUGS ARE MAKING THEM MORE FERTILE AND EXPERTS AGREE

“Those following a hypocaloric diet, as is the case with patients on GLP-1 agonists, may potentially inhibit healing and recovery from surgery, which requires a caloric surplus, particularly from protein-laden foods,” he said. 

Advertisement

Proper nutrition is crucial for tissue recovery, Osborn said.

Proper nutrition is essential to healing after surgery, a doctor said. (iStock)

“By inducing a relative state of malnutrition, these medications can be problematic in perioperative patients.”

Dr. Jean-Carlos Jimenez, medical director at Attune Med Spa in Connecticut, agreed that these medications can lead to complications during surgery.

ASK A DOCTOR: ‘WHAT SHOULD I DO, OR NOT DO, PRIOR TO SURGERY?’

Advertisement

“GLP-1 agonists can cause nausea, vomiting and something known as delayed gastric emptying, or gastroparesis — which means the stomach takes longer than usual to empty its contents into the small intestines,” he told Fox News Digital via email.

“Residual gastric content can increase the risk of pulmonary aspiration during anesthesia and potentially worsen post-operative recovery.”

Surgery is known to alter blood sugar levels due to stress from the procedure, a doctor noted. (iStock)

Surgery is also known to alter blood sugar levels due to stress from the procedure, Jimenez added.

Due to these risks, doctors agree that patients should review all the medications they’re taking with their surgeon and anesthesiologist. 

Advertisement

     

For surgical procedures that require patients to fast or remain on a clear liquid diet, they may need to do this for a longer period of time, said Jimenez.

“The timing of when to stop will depend on the type of GLP-1 agonists a patient uses, but can range from holding the daily dose on the day of surgery to holding the scheduled weekly dose one week before a planned procedure,” he told Fox News Digital.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

GLP-1s typically can be restarted at the next scheduled dose, but should be carefully monitored by the doctor, he advised.

Advertisement

The timing can depend on the type of surgery and the patient’s overall condition, according to Bonati.

Due to the risks, doctors say patients should review all their medications with the surgeon and anesthesiologist.  (iStock)

“It’s crucial to follow the instructions provided by the health care providers, as they will tailor the advice to your individual health needs and the specifics of your surgery,” he added.

In June 2023, the American Society of Anesthesiologists published an announcement warning of the risks and recommending that patients consider pausing their doses in the days or weeks leading up to an elective surgical procedure.

For more Health articles, visit www.foxnews/health

Advertisement

The American Association of Nurse Anesthesiology has issued a similar recommendation.

Fox News Digital contacted Novo Nordisk, maker of Ozempic and Wegovy, requesting comment.

Health

Hidden virus inside gut bacteria linked to doubled colorectal cancer risk, study finds

Published

on

Hidden virus inside gut bacteria linked to doubled colorectal cancer risk, study finds

NEWYou can now listen to Fox News articles!

A newly discovered virus hiding inside common gut bacteria may be linked to colorectal cancer, according to new research.

Scientists in Denmark found that colorectal cancer patients were about twice as likely to carry a previously unidentified virus within Bacteroides fragilis, a bacterium that normally lives in the human gut, according to the study published in Communications Medicine earlier this month.

Researchers say the discovery could help scientists better understand the role of the gut microbiome in cancer development.

JAMES VAN DER BEEK SHARED COLORECTAL CANCER WARNING SIGN MONTHS BEFORE HIS DEATH

Advertisement

“These findings highlight the importance of the microorganisms in the gut and their relation to our health,” Dr. Flemming Damgaard, PhD, of the Department of Clinical Microbiology at Odense University Hospital and the University of Southern Denmark, told Fox News Digital. “If we want to understand the full picture, we need to look deep into their genetic material.”

A new study suggests a virus living inside common gut bacteria may be linked to colorectal cancer. (iStock)

Doctors have known for years that Bacteroides fragilis shows up more often in people with colorectal cancer, which includes cancers of the colon and rectum, but since most healthy people also carry the bacteria, it wasn’t clear why it would be harmful in some cases and not others.

So researchers looked at subtle genetic differences within the bacteria and uncovered something unexpected.

COLORECTAL CANCER NOW DEADLIEST TYPE FOR CERTAIN GROUP OF AMERICANS, STUDY FINDS

Advertisement

“We were very surprised to find a whole virus inside the bacteria from the colorectal cancer patients,” Damgaard said. “That was not something we expected when we started our study.”

Scientists say the findings add to growing evidence that the gut microbiome may play a role in cancer development. (iStock)

The virus, known as a bacteriophage, infects bacteria rather than human cells. According to the researchers, the viral type they identified had not previously been documented.

When the team analyzed stool samples from 877 individuals across Europe, the United States and Asia, they found that colorectal cancer patients were approximately twice as likely to carry traces of the virus compared to people without cancer.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

The findings show a strong statistical association, but researchers stress that the study does not prove the virus causes colorectal cancer, and it is too early to draw immediate conclusions.

Researchers are continuing studies to explore whether the virus influences cancer growth. (iStock)

“The major limitation is that we still don’t know why the virus is linked to colorectal cancer,” said co-author Ulrik Stenz Justesen. “But we are already continuing our research.”

The team is now conducting laboratory experiments and animal studies to determine whether the virus alters the bacterium’s behavior in a way that could influence cancer development.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

Studies have found that the human body contains roughly as many microbial cells as human cells, underscoring how deeply microbes are intertwined with human health.

“Our understanding of [microbial cells] is still in its infancy,” Damgaard said. “There are many health-related discoveries to be made in the human microbiota.”

The discovery could one day help improve colorectal cancer screening. (iStock)

Colorectal cancer is one of the leading causes of cancer-related deaths worldwide, according to the World Health Organization. Several high-profile celebrity deaths, including James Van Der Beek, Catherine O’Hara, Kirstie Alley, Pelé and Chadwick Boseman, have drawn attention to colorectal cancer’s impact across age groups in recent years.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

While much of colorectal cancer risk is tied to diet and lifestyle, researchers think the bacteria in our gut may also play an important role.

Currently, colorectal cancer screening includes stool tests that check for blood that isn’t visible to the naked eye, as well as colonoscopies. Researchers say that in the future, it may be possible to test stool samples for viral markers like those identified in the study.

Actor James Van Der Beek died at age 48 after battling stage 3 colorectal cancer. (Ray Tamarra/GC Images)

Researchers pointed to cervical cancer as an example of how identifying a viral cause can help prevention efforts. After HPV was linked to cervical cancer, vaccines helped drive down new cases. 

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Advertisement

While it’s too early to make that comparison, they said colorectal cancer could one day follow a similar path if a clear viral role is confirmed.

“It is too early to act,” Damgaard said. “We have a lot of hope, and that is what we want people to have at this point.”

Fox News Digital’s Melissa Rudy contributed reporting.

Continue Reading

Health

Actor Eric Dane’s death from ALS sparks urgent focus on rapid decline

Published

on

Actor Eric Dane’s death from ALS sparks urgent focus on rapid decline

NEWYou can now listen to Fox News articles!

Eric Dane’s death has sparked conversations about the speed and severity of ALS.

Also known as Lou Gehrig’s disease, the progressive illness — officially called amyotrophic lateral sclerosis — is debilitating and fatal. 

While only about 5,000 people in the U.S. are diagnosed each year, the average life expectancy is just two to five years, according to the ALS Association.

Dane, who most famously starred as Dr. Mark “McSteamy” Sloan on ABC’s “Grey’s Anatomy,” announced his diagnosis in April 2025, telling “Good Morning America” in June that his first symptoms began as “some weakness” in his right hand.

Advertisement

‘GREY’S ANATOMY’ STAR ERIC DANE DEAD AT 53

“I didn’t really think anything of it,” the actor said. “At the time, I thought maybe I’d been texting too much, or my hand was fatigued. But a few weeks later, I noticed that it got a little worse.”

“I’m fighting as much as I can,” Dane added. “There’s so much about it that’s out of my control.”

Eric Dane starred as Dr. Mark “McSteamy” Sloan on “Grey’s Anatomy” for seven seasons. (Bob D’Amico/Disney General Entertainment Content via Getty Images)

What is ALS?

ALS is a progressive disease where the brain loses connection with the muscles, according to the ALS Association. This slowly strips a person’s ability to walk, talk, eat, dress, write, speak, swallow and, eventually, breathe.

Advertisement

Early signs include muscle weakness, stiffness and cramping. Symptom progression and severity are different for each case, as the association notes there is “no single timeline for ALS.”

REBECCA GAYHEART STEPS UP AS CAREGIVER FOR ESTRANGED HUSBAND ERIC DANE AS ALS DEMANDS 24-HOUR CARE

The disease only impacts motor neurons controlling voluntary movement, so the five senses — sight, touch, hearing, taste and smell — are not affected, nor are the eye muscles or bladder control.

ALS symptoms typically begin with muscle weakness in the upper extremities. (iStock)

Many ALS patients remain “mentally alert and aware” throughout the disease, the ALS Association reported.

Advertisement

Diagnosis typically occurs in people between the ages of 40 and 70. About 20% of patients live five years or longer. Only about 5% live longer than 20 years.

5 CELEBRITIES WHO WENT PUBLIC WITH ALARMING HEALTH DIAGNOSES IN 2025

ALS is typically diagnosed by a neurologist with an electromyography test (EMG), but can also be detected by blood and urine tests, spinal taps, MRIs and other imaging scans, muscle and nerve biopsies, or neurological exams.

There is currently no cure or treatment to stop disease progression, although there are treatments to slow and ease symptoms, per the ALS Association.

ALS can be diagnosed by a neurologist through various forms of testing. (iStock)

Advertisement

Fox News senior medical analyst Dr. Marc Siegel joined “Fox & Friends” on Friday to discuss the prevalence of ALS, suggesting that cases have increased due to “something in the environment that we don’t know yet.”

While ALS is 10% genetic, according to Siegel, 90% of cases do not have a genetic link, pointing toward other risk factors like environmental toxins.

“We’re learning to personalize the approach to this disease.”

“It’s a muscle weakness disease — affecting nerves that innervate muscles — and usually it starts on one side,” the doctor shared. “Then you develop fatigue … You could see a quivering tongue or your arm is quivering, usually one side and then the other side.”

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

As the weakness progresses, it impacts speech and ultimately attacks the diaphragm, making it difficult to fully inflate the lungs.

“That’s what happened to [Dane], most likely,” Siegel said. “So, it progresses from your arms, your legs, your speech, your swallowing ability and then your breathing.”

Rising research

ALS progresses “pretty rapidly in most cases,” Siegel said. While scientist Stephen Hawking lived 55 years with the disease, Dane “probably lived about two years with it,” the doctor surmised.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“I want to point out how courageous [Dane] is — he actually was involved with Target ALS, where he was fighting for new research,” Siegel pointed out. “We’re learning to personalize the approach to this disease, and that’s the future — and he fought for that.”

Advertisement

Actor Eric Dane is photographed at the St. Regis in Washington, D.C., on Sept. 30, 2025. “I want to point out how courageous [Dane],” said Dr. Marc Siegel. (Marvin Joseph/The Washington Post via Getty Images)

“We need a lot of money for research for this — [Dane] was asking for a billion dollars from the government.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Various research groups and hospital systems are actively working on new ALS therapies that take a personalized approach, Siegel shared.

The estimated cost to develop a drug that would slow or stop disease progression is $2 billion, the ALS Association has reported. The annual estimated out-of-picket cost for care is $250,000.

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Funding for ALS research and awareness has been on the rise for years, with the viral social media ALS Ice Bucket Challenge making a splash in 2014. 

The challenge, supported by the ALS Association, was intended to boost awareness. It ultimately raised $115 million toward ALS research and patient care.

Continue Reading

Health

The Viral 3-Day Sardine Fast Can Help You Lose Weight When Nothing Else Works

Published

on

The Viral 3-Day Sardine Fast Can Help You Lose Weight When Nothing Else Works


Advertisement




Does the Viral Sardine Fast for Weight Loss Really Work? | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Trending